Cooler Heads for Better Outcomes for Some Infants

Years of international clinical trials aimed at reducing brain injury in full-term infants who have experienced low oxygen before or during birth have ended with the U.S. Food and Drug Administration's (FDA) stamp of approval on a small cooling cap that puts a baby's brain in a mild state of hypothermia.

Within a five day period in early March, neonatologists at Arkansas Children's Hospital received not only the first infant in the world to require treatment from the FDA-approved cooling cap technology, but three of the first four infants to need such treatment.

For more information, visit http://www.archildrens.org.

Category:

People & Blogs